IKZF1 deletion
|
AML
|
IKZF1 deletion
|
AML
|
ponatinib Resistant: C3 – Early Trials
|
ponatinib Resistant: C3 – Early Trials
|
IKZF1 deletion
|
ALL
|
IKZF1 deletion
|
ALL
|
dasatinib + blinatumomab Resistant: C3 – Early Trials
|
dasatinib + blinatumomab Resistant: C3 – Early Trials
|
IKZF1 deletion
|
ALL
|
IKZF1 deletion
|
ALL
|
dasatinib Sensitive: C3 – Early Trials
|
dasatinib Sensitive: C3 – Early Trials
|
IKZF1 deletion
|
ALL
|
IKZF1 deletion
|
ALL
|
cytarabine Resistant: D – Preclinical
|
cytarabine Resistant: D – Preclinical
|